Package 0409-1208-01

Brand: cisatracurium besylate

Generic: cisatracurium besylate
NDC Package

Package Facts

Identity

Package NDC 0409-1208-01
Digits Only 0409120801
Product NDC 0409-1208
Description

10 VIAL, MULTI-DOSE in 1 CARTON (0409-1208-01) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1208-11)

Marketing

Marketing Status
Marketed Since 2020-03-24
Brand cisatracurium besylate
Generic cisatracurium besylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0ec666c8-db68-4a59-9da4-e0abd8e209c5", "openfda": {"unii": ["80YS8O1MBS"], "rxcui": ["199211", "199212", "1730194"], "spl_set_id": ["67908e20-044d-454d-9c51-bf106e817bd0"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (0409-1208-01)  / 10 mL in 1 VIAL, MULTI-DOSE (0409-1208-11)", "package_ndc": "0409-1208-01", "marketing_start_date": "20200324"}], "brand_name": "Cisatracurium Besylate", "product_id": "0409-1208_0ec666c8-db68-4a59-9da4-e0abd8e209c5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "0409-1208", "generic_name": "CISATRACURIUM BESYLATE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA203238", "marketing_category": "ANDA", "marketing_start_date": "20200324", "listing_expiration_date": "20261231"}